Abbas Ahmadi, Mohsen Khalili, Ramin Hajikhani, Horiesadat Hosseini, Nasrin Afshin and Babak Nahri-Niknafs Pages 246 - 251 ( 6 )
Ketamine (2-o-chlorophenyl-2-methylaminocyclohexan, CAS 1867-66-9, CI-581, Ketalar, I), a potent derivative of Phencyclidine (1-[1-phenylcyclohexyl] piperidine, CAS 956-90-1, PCP, II), and many of its analogues have shown anesthetic and analgesic effects. In this research, new derivatives of I, (2-[p-methoxybenzylamino]-2-[p-methoxyphenyl] cyclohexanone, ket-OCH3, III), (2-[p-methylbenzylamino]-2-[p-methoxyphenyl] cyclohexanone, ket-CH3, IV) and their intermediates (V-VIIII) were synthesized and the acute and chronic pains of III and IV were evaluated on rats using tail immersion (as a model of acute thermal pain) and formalin (as a model of acute and chronic chemical pain) tests. The results werecompared with ketamine and control (saline) groups. The results indicated that in tail immersion and formalin tests, these new derivatives (III and IV) were usually effective for decreasing pain on rats.
Acute and chronic pains, analgesic effects, CAS 1867-66-9, CAS 956-90-1, formalin test, new derivatives of ketamine, tail immersion test, Wistar Rats, binding sites, Melting points, magnesium
Department of Chemistry, Faculty of Science, Islamic Azad University, P.O.Box: 31485-313, Karaj, Iran.